In 2026, advanced therapies diverge: winners pair proven biology with scalable manufacturing, delivery, and workflow fit, while others advance more slowly under operational and economic limits.
- In Vivo's Biggest Threat — Comparison To Old Models
- The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing
- Why Use Total Organic Carbon Analysis For Cleaning Validation?
- December 2025 — CDMO Opportunities And Threats Report
- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Single-Use Standards Are Maturing, But The Process Remains King
- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026
- Deploying A Vendor Life Cycle Oversight Model
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2166558808-data-gene-dna-genomic]( "Partner Case Study: Accelerating Gene Editing Manufacturing")
Partner Case Study: Accelerating Gene Editing ManufacturingBeam Therapeutics partnered with ElevateBio to manufacture BEAM-101, a novel base editing therapy for sickle cell disease, advancing rapid, high-quality production towards clinical trials.
-
![Emergent BioSolutions]( "Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer")
Aseptic Filling Solution Enhances Sterility Assurance for Pharma ManufacturerEmergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
![GettyImages-1435534172-mesenchymal-stem-cells]( "Enabling Rapid, High-Yielding, Stable Cell Line Development")
Enabling Rapid, High-Yielding, Stable Cell Line DevelopmentDiscover how to simplify and accelerate CHO-S stable cell line development, eliminating the need for extensive screening of candidate clones and specialized equipment.
-
![GettyImages-1352861391 Doctor holding decorative model intestine]( "Modeling Inflammation-Specific Immune Cell Recruitment")
Modeling Inflammation-Specific Immune Cell RecruitmentTraditional models for studying inflammatory bowel disease (IBD) often fall short. See how the Colon Intestine-Chip was used to model the progression of IBD driven by immune cells more completely.
-
![GettyImages-1441343945-virus-viral-infection]( "Enhanced Development Of Virus-Specific Hybridomas")
Enhanced Development Of Virus-Specific HybridomasDouble-stranded DNA viruses cause various human diseases, which complicates diagnosis due to antigen conservation. Explore a cell line that produces specific monoclonal antibodies to aid biotherapeutics development.
-
![GettyImages-2200128716-software-ai-machine-learning-percentages-code]( "Building Digital Capabilities For An Intelligent Tomorrow")
Building Digital Capabilities For An Intelligent TomorrowExplore how modern manufacturing software is transforming operations with AI-driven insights to empower CDMOs and CMOs to boost efficiency, agility, and client satisfaction in a competitive landscape.
-
![GettyImages-1181392775 lab, research]( "Predicting Antibody-Dependent Cell-Mediated Cytotoxicity")
Predicting Antibody-Dependent Cell-Mediated CytotoxicityWe developed and validated a dual screening procedure (genotype and phenotype) for Lonza human peripheral blood mononuclear cells (PBMCs) to identify donors with high ADCC potential.
-
![GettyImages-1214111376 scientists computer]( "Monitoring Bioprocesses In A Light Environment Using Raman Spectroscopy")
Monitoring Bioprocesses In A Light Environment Using Raman SpectroscopyDiscover an advanced solution to facilitate the implementation of Raman technology at both laboratory and manufacturing scales in a normal light environment.
-
![GettyImages-1289625867 chromatography]( "Simplify Your Bioprocess Development With Custom Buffers")
Simplify Your Bioprocess Development With Custom BuffersTailor your bioprocess for optimal cell growth, gene expression, and therapeutic production with custom buffers to ensure precise control over pH, ion concentrations, and nutrient availability.
-
![GettyImages-2165310987-chromosome-nucleotide-gene]( "Modern Lentiviral Platforms For Scalable Cell Therapy")
Modern Lentiviral Platforms For Scalable Cell TherapyA new platform approach streamlines lentiviral vector design and manufacturing, boosting yield, lowering costs, and accelerating access to gene‑modified cell therapies worldwide.
NEWSLETTER ARCHIVE
- 01.30.26 -- Reclaiming Control From Your Raw Materials
- 01.29.26 -- Advancing Off-The-Shelf CRISPR CAR-T Therapies With Rachel Haurwitz
- 01.28.26 -- Single-Use Standards Are Maturing, But The Process Remains King
- 01.27.26 -- STREAM Edition: Advancing Off-The-Shelf CRISPR CAR-T Therapies Into The Community Setting With Caribou Biosciences' Rachel Haurwitz
- 01.27.26 -- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026
- Global Shifts And Strategic Resilience Will Shape CGT In 2026
- Why Efficiency In Multi-Modal CGT Manufacturing Is About Execution, Not Just Cost
- CSL's HEMGENIX Shows Durable Benefit, A New Future For Gene Therapy in Hemophilia B
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
